Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas.

PURPOSE Accurate diagnosis of tumor extent is important in three-dimensional conformal radiotherapy. This study reports the use of image fusion between (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG-PET) and magnetic resonance imaging/computed tomography (MRI/CT) for better targets delineation in radiotherapy planning of head-and-neck cancers. METHODS AND MATERIALS The subjects consisted of 12 patients with oropharyngeal carcinoma and 9 patients with nasopharyngeal carcinoma (NPC) who were treated with radical radiotherapy between July 1999 and February 2001. Image fusion between 18FDG-PET and MRI/CT was performed using an automatic multimodality image registration algorithm, which used the brain as an internal reference for registration. Gross tumor volume (GTV) was determined based on clinical examination and 18FDG uptake on the fusion images. Clinical target volume (CTV) was determined following the usual pattern of lymph node spread for each disease entity along with the clinical presentation of each patient. RESULTS Except for 3 cases with superficial tumors, all the other primary tumors were detected by 18FDG-PET. The GTV volumes for primary tumors were not changed by image fusion in 19 cases (89%), increased by 49% in one NPC, and decreased by 45% in another NPC. Normal tissue sparing was more easily performed based on clearer GTV and CTV determination on the fusion images. In particular, parotid sparing became possible in 15 patients (71%) whose upper neck areas near the parotid glands were tumor-free by 18FDG-PET. Within a mean follow-up period of 18 months, no recurrence occurred in the areas defined as CTV, which was treated prophylactically, except for 1 patient who experienced nodal recurrence in the CTV and simultaneous primary site recurrence. CONCLUSION This preliminary study showed that image fusion between 18FDG-PET and MRI/CT was useful in GTV and CTV determination in conformal RT, thus sparing normal tissues.

[1]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[2]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[3]  R. Baum,et al.  Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[4]  K. Greven,et al.  Occult primary tumors of the head and neck , 1999, Cancer.

[5]  S. Ng,et al.  Nasopharyngeal carcinoma: MRI and CT assessment , 1997, Neuroradiology.

[6]  P. Goddard,et al.  Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging. , 1999, Journal of computer assisted tomography.

[7]  P. V. van Rijk,et al.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. , 2000, Annals of surgery.

[8]  G. Tracton,et al.  Image registration: an essential part of radiation therapy treatment planning. , 1998, International journal of radiation oncology, biology, physics.

[9]  S. Stringer,et al.  SQUAMOUS CELL CARCINOMA METASTATIC TO CERVICAL LYMPH NODES FROM AN UNKNOWN HEAD AND NECK PRIMARY SITE , 1998 .

[10]  U. Pietrzyk,et al.  2[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography is a Sensitive Tool for the Detection of Occult Primary Cancer (Carcinoma of Unknown Primary Syndrome) with Head and Neck Lymph Node Manifestation , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[11]  D A Low,et al.  Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.

[12]  P. Xia,et al.  Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. , 2000, International journal of radiation oncology, biology, physics.

[13]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[14]  H Shirato,et al.  Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. , 2001, International journal of radiation oncology, biology, physics.

[15]  B. Ardekani,et al.  A Fully Automatic Multimodality Image Registration Algorithm , 1995, Journal of computer assisted tomography.

[16]  Josien P. W. Pluim,et al.  Image Registration , 2003, IEEE Trans. Medical Imaging.

[17]  R. Hustinx,et al.  18FDG‐PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients , 1998, The Laryngoscope.

[18]  C. Fallai,et al.  Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. , 1995, International journal of radiation oncology, biology, physics.

[19]  A. Garden,et al.  Can positron emission tomography improve the quality of care for head-and-neck cancer patients? , 2001, International journal of radiation oncology, biology, physics.

[20]  K. Kagei,et al.  A new mold material for customized patient positioning in radiotherapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  J C de Munck,et al.  Automatic registration of pelvic computed tomography data and magnetic resonance scans including a full circle method for quantitative accuracy evaluation. , 1998, Medical physics.

[22]  S. Fukuda,et al.  Skull-base invasion of nasopharyngeal carcinoma: magnetic resonance imaging findings and therapeutic implications. , 2000, International journal of radiation oncology, biology, physics.

[23]  R. Coleman,et al.  PET in lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  G. Hör,et al.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer , 1998, European Journal of Nuclear Medicine.

[25]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[26]  M Schwaiger,et al.  First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. , 2000, International journal of radiation oncology, biology, physics.

[27]  J A Werner,et al.  FDG PET detection of unknown primary tumors. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  A. Alavi,et al.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.

[29]  S U Berlangieri,et al.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.

[30]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[31]  P C Goodman,et al.  Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.

[32]  M. Singer,et al.  Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. , 1999, Radiology.

[33]  C B Caldwell,et al.  Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.